Industry Focus

View Top 200 Chart

Back to Rankings Page

Business
**Industry Focus**

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Latest Episodes:

Healthcare: The Best Buys in Biopharma May 11, 2016

Show notes

GlaxoSmithKline takes on Pfizer and Biogen battles Celgene in this healthcare edition of Industry Focus.

CG: How To Take Advantage of Big Changes in the Online Streaming and Coffee Industries May 10, 2016

Show notes

Big changes are happening in the world of entertainment and coffee consumption, here’s how investors can position their portfolios.

Financials: Will Bank of America and Merrill Lynch Eventually Go Their Separate Ways? May 09, 2016

Show notes

There's reason to believe that they will.

It's been nearly eight years since the financial crisis, yet Bank of America (NYSE: BAC) is still earning half as much money as it should be given its size. In this episode of Industry Focus: Financials, The Motley Fool's Gaby Lapera and John Maxfield discuss the role that Bank of America's 2008 purchase of Merrill Lynch plays in its subpar profitability. Thanks to Audible for supporting this episode. Get a free 30-day trial at audible.com/fool.

Tech: Stock Splits -- No Matter How You Slice It May 06, 2016

Show notes

We discuss stock splits, the strategy behind them, and why Facebook announced they were using C shares to offer investors a 3-to-1 split.

Energy: Tesla Motors Just Put its Growth Pedal to the Metal May 05, 2016

Show notes

If Tesla Motors plans for growth and its new Model 3 weren't ambitious enough, it now wants to make it all happen by 2018. Plus, earnings from Royal Dutch Shell, BHP Billiton & Vale's nightmare situation, and we dip into the mailbag.

Healthcare: Digging Into Disappointment. What Investors Need To Know About Sarepta and Gilead Sciences' "Bad News" May 04, 2016

Show notes

Discussing the details behind the FDA's negative vote on Sarepta's DMD drug and Gilead Sciences' sliding hepatitis C sales.

CG: Watch Out Disney, Comcast Expands Its Film Business With Dreamworks Acquisition May 03, 2016

Show notes

At $3.8 billion, Dreamworks founder and CEO Jeffrey Katzenberg called the buyout “the deal I’d always hoped would come along.” But after a major restructuring and string of box office disappointments for the animation studio, is Comcast getting its money’s worth?

Financials: Your 23-Minute Guide to Berkshire Hathaway's Annual Meeting May 02, 2016

Show notes

Berkshire Hathaway’s annual meeting is often referred to as “Woodstock for capitalists.” Join us to learn why… from someone who was there!

Tech: Apple – Then and Now Apr 30, 2016

Show notes

We call on old Industry Focus host Nathan Hamilton to run through Apple’s recent earnings report and provide some perspective on how the company has changed in the past year.

Energy: Looking Back on Energy’s Glory Days and Predicting the Future Apr 29, 2016

Show notes

What we got right and what we got incredibly wrong in our predictions for the energy sector two years ago.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected